title: Self-reported psychological distress associated with steroid therapy for HIV.
abstract: Anabolic androgenic steroid (AAS) replacement therapy is standard care for patients with low testosterone, including HIV-related conditions. These medications have been associated with development of aggressiveness, anxiety disorders, and depression, but only in short-term clinical trials. We conducted an anonymous street survey at a gay and lesbian community event and a survey in a clinic-based setting to study the wider prevalence of psychiatric side-effects associated with androgenic steroids. In the street-based survey, almost half of those prescribed AAS reported psychological side-effects, most commonly aggression (29%) followed by depression (21%). In the clinic survey of mostly HIV+ male patients, changes in sex drive were the most commonly reported effect of treatment while impulsive aggression, anxiety and depression were reported at levels similar to those in the street fair survey. These findings suggest that AAS therapy may be more frequently associated with distress than has been reported in the clinical literature.
authors.affiliation: Great Cities Institute, University of Illinois at Chicago, Chicago, IL, USA.
authors.forename: T
authors.initials: T
authors.lastname: Lyons
authors.forename: D
authors.initials: D
authors.lastname: Berger
authors.forename: B
authors.initials: B
authors.lastname: Masini
authors.forename: G
authors.initials: G
authors.lastname: Pinna
mesh_terms: D000328:Adult; D000728:Androgens / Q000008:administration & dosage* / Q000009:adverse effects*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000523:psychology*; D006801:Humans; D008297:Male; D015995:Prevalence; D013315:Stress, Psychological / Q000139:chemically induced* / Q000453:epidemiology*
chemical_list: D000728:Androgens